The LSD1/HDAC dual-target inhibitor for cancer therapy: Challenge and opportunity

Authors:

Abstract
No abstract available
Funding Information
  • Henan Provincial Science and Technology Research Project (252102311176, 242102311236)
  • China Postdoctoral Science Foundation (2024M750818)
  • National Natural Science Foundation of China (82304286, 82303741)

This publication has 60 references indexed in Scilit: